Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-23

Clinical Trial Update: Investigating the Therapeutic Efficacy of All-trans Retinoic Acid in Autism Spectrum Disorder Patients With 15q11-13 Duplication Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating the efficacy of all-trans retinoic acid for autism spectrum disorder associated with duplication of the 15q11-13 regio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • All-trans Retinoic Acid (all-trans retinoic acid)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Dup15q Syndrome, Autism Spectrum Disorder | Phase 2 | Status: NOT_YET_RECRUITING